Search results
...Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula,...
Benzinga· 1 hour agoModerna added that clinical development and manufacturing expenses also decreased, driven by lower...
Moderna posts quarterly sales beat, smaller loss than expected
Reuters via Yahoo Finance· 8 hours ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 2 hours agoModerna Stock: Big Sales Beat During the first quarter, sales of its Covid vaccine plummeted nearly...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 8 hours agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts ...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 hours agoIt is nice to see a company recognizing our IP and asking us for a license. Second, we recently announced a contract to provide 12.5 million doses of ...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 4 hours ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 13 hours agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 8 hours agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo Finance· 8 hours agoModerna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19</ ...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 8 hours agoModerna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine...
